Vaxcyte Inc.’s stock fell 3% early Friday, after the company completed a stock offering that is expected to generate $1.42 billion in proceeds.
Vaxcyte’s stock dips after biotech completes $1.42 billion stock offering
I sincerely hope that in the coming new year of 2025,
all your wishes will come true,
and you will be filled with joy and happiness.
Happy New Year
